UCB at once celebrates diversity and focuses on the competencies and contributions each person brings to the company and society as a whole. Pride Month is the perfect time to reiterate our commitment and pledge to fostering a truly inclusive working culture, grounded in fundamental respect for everyone. In that spirit, we are pleased to share the story of Jan Berger, a member of the Board of Directors at UCB and a proud member of the LGBTQIA+ community.

At UCB, people are at the heart of everything we do and part of our commitment to delivering impactful solutions for people whose lives have been challenged by severe disease is by deeply understanding their disease. This week is Hidradenitis Suppurativa (HS) Awareness Week and we’re sharing information on this lesser-known inflammatory, chronic autoimmune skin disease.

Today, UCB was pleased to host Her Royal Highness Princess Astrid of Belgium (HRH), Belgian dignitaries, and Belgian business leaders to visit our U.S. headquarters in Atlanta, Georgia.

Clinical studies are an essential part of biopharmaceutical research on the journey to discover, develop and deliver new solutions to people living with severe diseases. This Clinical Trial Awareness week, UCB thanks all of the participants in UCB studies and the dedicated researchers doing this important work.

UCB congratulates Kerry Black, Head of Early Solutions U.S. Operations, and Brooke Fleming, Head of Omnichannel Marketing and Digital Enablement, for their recognition by the Healthcare Businesswomen's Association (HBA) as 2022 Luminary and Rising Star, respectively.